Jan 10, 2023 / 05:00PM GMT
Rachel Marie Vatnsdal Olson - JPMorgan Chase & Co, Research Division - Analyst
Perfect. Hello, everyone. This is Rachel Vatnsdal from the Life Science Tools and Diagnostics team. Thank you so much for joining us today. So I'm joined with the Agilent team, Mike McMullen, CEO. Standard with the other sessions that you've been attending today, we'll kick it off with a 20-minute presentation by the company, and then we will shift to Q&A.
During Q&A, if you're joining via webcast, you can feel free to submit a question via the Q&A function. And for those of us in person, feel free to raise your hand, and we have mic runners throughout the room that can hand a microphone off to you. With that, thank you so much.
Michael R. McMullen - Agilent Technologies, Inc. - CEO, President & Director
Well, thank you, Rachel. I know I say, as I mentioned earlier, it's just great to be here and must be -- it's great to be back in a phased environment here at JPMorgan. So thanks for joining today. There's 3 parts to my talk today. First of all, I'm going
Agilent Technologies Inc at JPMorgan Healthcare Conference Transcript
Jan 10, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers